Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds.Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so.Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body 2 days ago &0183 &32 IBD Stock Of The Day Sarepta Therapeutics will lead the gene therapy market for Duchenne muscular dystrophy, an analyst said Monday as he boosted his price target on SRPT stock.
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services.Obtains access to the information in a personal capacity The Fidelity Freedom Index target-date series’ deep global asset-allocation team, research-driven approach, and attractive price earn all share classes a Morningstar.I am a private investor* I am not a private investor *A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
0 kommentar(er)
